The relationship between insulin resistance and endothelial dysfunction in obese adolescents

Journal of Pediatric Endocrinology & Metabolism : JPEM
Preneet Cheema BrarStuart Katz

Abstract

Insulin resistance and endothelial dysfunction share a reciprocal relationship that links the metabolic and cardiovascular sequelae of obesity. We characterized the brachial artery reactivity testing (BART) and carotid artery-intima media thickness (CIMT) in adolescents categorized as obese insulin resistant (OIR) and obese not insulin resistant (ONIR). Lipoprotein particle (p) analysis and inflammatory cytokines in OIR and ONIR groups were also analyzed. Obese adolescents (n=40; mean body mass index [BMI] 35.6) were categorized as ONIR and OIR based on their homeostatic model assessment of insulin resistance (HOMA-IR) calculation (≤or> than 3.4). Ultrasound measured conduit arterial function BART, microvascular function (post-ischemic hyperemia) and conduit artery structure CIMT. BART did not differ according to IR status (mean±SD: 7.0±4.3% vs. 5.9±3.4% in ONIR and OIR, respectively, p=0.3, but post-ischemic hyperemia was significantly greater in the ONIR group (4.5±2.2 vs. 3.5±3, p=0.04). Atherogenic lipoprotein particles; large VLDL particles and small LDL particles were higher in the OIR compared to ONIR group. OIR adolescents demonstrate an inflamed atherogenic milieu compared to the ONIR adolescents. Microvascular functio...Continue Reading

References

Sep 1, 1995·Hypertension·D HayozH R Brunner
Dec 1, 2004·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M NeoviusS Rossner
Mar 16, 2005·Hypertension·Giovanni de SimoneRichard B Devereux
Jun 29, 2006·American Journal of Physiology. Endocrinology and Metabolism·Git S Johansson, Hans J Arnqvist
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Ranganath Muniyappa, Michael J Quon
Sep 9, 2008·Endocrinology and Metabolism Clinics of North America·Ranganath MuniyappaMichael J Quon
Mar 31, 2010·Hypertension·Ryan A HarrisRussell S Richardson
Sep 11, 2010·The Journal of Clinical Endocrinology and Metabolism·Claire Levy-MarchalUNKNOWN Insulin Resistance in Children Consensus Conference Group
Mar 4, 2011·The Journal of Clinical Endocrinology and Metabolism·Sheela N MaggeDaniel J Rader
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·David MonteroAgnès Vinet
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Amy S ShahLawrence M Dolan
May 6, 2014·International Journal of Cardiology·Vito Leonardo MinielloMarco Matteo Ciccone
Aug 17, 2014·American Journal of Hypertension·Qurat-Ul-Ain JelaniStuart D Katz
Sep 10, 2014·The Journal of Clinical Endocrinology and Metabolism·Dorothee NewbernMichael Freemark
Mar 7, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Michelle T LongNaomi M Hamburg
Aug 15, 2015·Journal of Diabetes Research·M P van der AaM M J van der Vorst

❮ Previous
Next ❯

Citations

Nov 28, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Eman M AlissaZuhair M Marzouki
Dec 21, 2019·Cardiovascular Diabetology·Preneet Cheema BrarShelby Kutty

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance
metabolomic profiling

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.